OpenVSafe by OpenVAERS
Search V-safe

44S-16823-53951

3 vaccinations 10 coded responses 21 check-ins 10 free-text entries 5 call cases
Sex
Male
Age at first dose
56-60
ZIP prefix
917 / CA
Registered
2021-05-01
Relationship
Self
Race
Native Hawaiian or other Pacific Islander
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
1925115 (opens in a new window) high 11 / 11 1 2 of 4 VAERS symptoms same dose (2) CA matches 2021-04-28 / 2021-05-12 / 2021-12-06
received 35 days after the last call
case 1137254

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-04-07
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-28
    Dose 2 — Pfizer-BioNTech
  3. 2021-05-01
    Registered in v-safe
  4. 2021-05-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Headache, Nasal congestion — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Free text: Severe nasal congestion at bed time. Dull headache most of today. Not sure if it's related as 2nd shot was 4/28, today is 5/1.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-05-02
    Survey response — days 1–6 daily, dose 2
    MedDRA: Headache, Increased viscosity of upper respiratory secretion, Insomnia, Nasal congestion, Nasal mucosal discolouration, Respiratory tract congestion, Sleep disorder — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Free text: ~8-9.5(rating) nasal congestion that is causing my ongoing 5-7 (day-night time rating) headaches. I discharged yellow-green very thick mucus this morning. Congestion severe enough to prove difficult sleeping even in upright position; waking up 2x at night.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-05-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · None
    Adult check-in
  7. 2021-05-05
    Survey response — day 7, dose 2
    MedDRA: Respiratory tract congestion — Feeling: Fair · Rash, not including the immediate area around the injection site
    Free text: I continue, albeit much reduced, chest congestion. I think it's almost gone.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-05-12
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  9. 2021-05-19
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-05-26
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-06-02
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-06-09
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  13. 2021-07-28
    Survey response — 3 months, dose 2
    MedDRA: Bronchitis, Telemedicine — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Bronchitis mid May to early July. Pulmonary function test 7/29/21 10:00am. Meds: 2 rounds ea. of steroids, azythromycin, advair. · Healthcare visit (other): 1st round telehealth 1st rnd of meds; 2nd round expedited appt Dr appt for 2nd rnd of stronger meds.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  14. 2021-07-28
    Report sent to call center — 3 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  15. 2021-08-10
  16. 2021-08-16
    Call successful
    Completed over the phone
  17. 2021-10-29
    Survey response — 6 months, dose 2
    MedDRA: Bronchitis, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professional
    Free text: Symptoms: My bronchitis that I first contracted(?) has returned 2 times. Now it seems to be a residual condition that's exacerbated by moderate exercise. I'm very discouraged and dont know what to do, after two pulmonologists & multiple steroids & Rx's. · Healthcare visit (other): Pulmonologist appts. Seeking more help.
    MedDRA releases: 2024-11 · check-in free text available
  18. 2021-10-29
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  19. 2021-11-01
    Call successful
    Completed over the phone
  20. 2021-11-09
    Dose 3 — Pfizer-BioNTech
  21. 2021-11-15
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · None
    Adult check-in
  22. 2021-11-16
    Survey response — day 7, dose 3
    MedDRA: Bronchitis, Bronchospasm, Office visit, Respiratory tract congestion — Feeling: Fair · Get care from a doctor or other healthcare professional
    Free text: Systemic reaction (other): Continued residual congestion from bronchitis in May continuing with bouts of exercise induced broncoconstriction. · Healthcare visit (other): Appt 11/29/21 allergist / immunologist / internal medicine
    MedDRA releases: 2024-11 · check-in free text available
  23. 2021-11-16
    Report sent to call center — day 7, dose 3
    Get care from a doctor or other healthcare professional
    1 call case(s)
  24. 2021-11-18
  25. 2021-11-25
    Health check-in — day 14, dose 3
    Feeling: Fair
    Adult check-in
  26. 2021-11-29
    Call successful
    Completed over the phone
  27. 2021-12-01
    Survey response — day 21, dose 3
    MedDRA: Asthenia, Cough, Dyspnoea, Headache, Office visit, Pain, Telemedicine — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Coughing shortness of breath headache body aches weakness. Immunologist gave me 2 doses ea epinephrine and albuterol by nebulizer. Dr ordered STAT lab and chest CT for review for next app 12/2/21. · Healthcare visit (other): Outpatient-immunologist Telehealth-PCP
    MedDRA releases: 2024-11 · check-in free text available
  28. 2021-12-01
    Report sent to call center — day 21, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  29. 2021-12-06
    Call successful
    Completed over the phone
  30. 2021-12-07
    Survey response — day 28, dose 3
    MedDRA: Hospitalisation, Respiratory disorder, Unevaluable event — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    Free text: Symptoms: As discussed in my recent vsafe phone conversation with your rep. I remain hospitalized due to respitory health problems. I gave specific medical info where I'm hospitalized and my doctors. · Healthcare visit (other): Info already given in my last phone check up with your vsafe rep.
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-12-07
    Report sent to call center — day 28, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  32. 2021-12-09
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  33. 2021-12-14
    Health check-in — day 35, dose 3
    Feeling: Poor
    Adult check-in
  34. 2021-12-23
    Health check-in — day 42, dose 3
    Feeling: Fair
    Adult check-in
  35. 2022-02-08
    Survey response — 3 months, dose 3
    MedDRA: Eosinophilic granulomatosis with polyangiitis, Pre-existing disease, Vasculitis — Feeling: Fair
    Free text: Since been diagnosed wi/asthma, later changed to a symptom of new diagnosis called Eosinophilic granulomatosis with polyangiitis (EGPA), a rare form of vasculitis that restricts blood vessels and damage vital organs.
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-05-11
    Health check-in — 6 months, dose 3
    Feeling: Fair
    Adult check-in
  37. 2022-11-09
    Survey response — 12 months, dose 3
    MedDRA: Discomfort, Ear discomfort, Fatigue, Head discomfort, Headache — Feeling: Fair
    Free text: They may be related to EGPA; dull headaches, head, ear, nos, face pressure, tiredness. But symptoms are not debilitating as to prevent my willingness & ability to work, and ADLs.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-04-07Pfizer-BioNTech
22021-04-28Pfizer-BioNTech
32021-11-09Pfizer-BioNTech No

Call center

5 call center cases

5 successful

VAERS report filed, before or during a call: 4

See the call center timeline

Free text

Release 8 — days 1–6 daily, dose 2

2021-05-01

Systemic reaction (other): Severe nasal congestion at bed time. Dull headache most of today. Not sure if it's related as 2nd shot was 4/28, today is 5/1.

2021-05-02

Systemic reaction (other): ~8-9.5(rating) nasal congestion that is causing my ongoing 5-7 (day-night time rating) headaches. I discharged yellow-green very thick mucus this morning. Congestion severe enough to prove difficult sleeping even in upright position; waking up 2x at night.

Release 8 — day 7, dose 2

2021-05-05

Systemic reaction (other): I continue, albeit much reduced, chest congestion. I think it's almost gone.

Release 9 — 3 months, dose 2

2021-07-28

Symptoms: Bronchitis mid May to early July. Pulmonary function test 7/29/21 10:00am. Meds: 2 rounds ea. of steroids, azythromycin, advair.
Healthcare visit (other): 1st round telehealth 1st rnd of meds; 2nd round expedited appt Dr appt for 2nd rnd of stronger meds.

Release 10 — 6 months, dose 2

2021-10-29

Symptoms: My bronchitis that I first contracted(?) has returned 2 times. Now it seems to be a residual condition that's exacerbated by moderate exercise. I'm very discouraged and dont know what to do, after two pulmonologists & multiple steroids & Rx's.
Healthcare visit (other): Pulmonologist appts. Seeking more help.

Release 10 — day 7, dose 3

2021-11-16

Systemic reaction (other): Continued residual congestion from bronchitis in May continuing with bouts of exercise induced broncoconstriction.
Healthcare visit (other): Appt 11/29/21 allergist / immunologist / internal medicine

Release 10 — day 21, dose 3

2021-12-01

Symptoms: Coughing shortness of breath headache body aches weakness. Immunologist gave me 2 doses ea epinephrine and albuterol by nebulizer. Dr ordered STAT lab and chest CT for review for next app 12/2/21.
Healthcare visit (other): Outpatient-immunologist Telehealth-PCP

Release 10 — day 28, dose 3

2021-12-07

Symptoms: As discussed in my recent vsafe phone conversation with your rep. I remain hospitalized due to respitory health problems. I gave specific medical info where I'm hospitalized and my doctors.
Healthcare visit (other): Info already given in my last phone check up with your vsafe rep.

Release 11 — 3 months, dose 3

2022-02-08

Symptoms: Since been diagnosed wi/asthma, later changed to a symptom of new diagnosis called Eosinophilic granulomatosis with polyangiitis (EGPA), a rare form of vasculitis that restricts blood vessels and damage vital organs.

Release 12 — 12 months, dose 3

2022-11-09

Symptoms: They may be related to EGPA; dull headaches, head, ear, nos, face pressure, tiredness. But symptoms are not debilitating as to prevent my willingness & ability to work, and ADLs.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
HCVOTelemedicine ✓ · ✓
HCVOUnevaluable event · · ✓
SDAsthenia · · ✓
SDBronchitis ✓ · ✓
SDCough · · ✓
SDDiscomfort · · ✓
SDDyspnoea · · ✓
SDEar discomfort · · ✓
SDEosinophilic granulomatosis with polyangiitis · · ✓
SDFatigue · · ✓
SDHead discomfort · · ✓
SDHeadache · · ✓
SDHospitalisation · · ✓
SDOffice visit · · ✓
SDPain · · ✓
SDPre-existing disease · · ✓
SDRespiratory disorder · · ✓
SDVasculitis · · ✓
SROBronchitis · · ✓
SROBronchospasm · · ✓
SROHeadache ✓ ✓ ✓
SROIncreased viscosity of upper respiratory secretion ✓ ✓ ✓
SROInsomnia ✓ ✓ ✓
SRONasal congestion ✓ ✓ ✓
SRONasal mucosal discolouration ✓ ✓ ✓
SRORespiratory tract congestion ✓ ✓ ✓
SROSleep disorder ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release